The Significance of the Expression of DLL4 and VEGF in Patients with Bladder Transitional Cell Carcinoma

Ejun PENG,Liang CHEN,Fei LIU,Xiaoyong ZENG,Zhiquan HU,Qianyuan ZHUANG,Zhangqun YE
DOI: https://doi.org/10.3969/j.issn.1001-1420.2011.09.014
2011-01-01
Journal of Clinical Urology
Abstract:Objective:To investigate the expression pattern and significance of DLL4 and VEGF in bladder transitional cell carcinoma(BTCC).Methods:The expression of DLL4 and VEGF in 50 patients with BTCC and 10 specimens of normal bladder tissue was analyzed by immunohistochemical method(Streptavidin/Peroxidase) and the expression level of DLL4 and VEGF was detected by computer graph analysis system.Compare the expressions of DLL4 and VEGF in different grades and pathological stages of BTCC.Results.DLL4 and VEGF were both positive expression in patients with BTCC,the rate of the positive expression were 90%(45/50) and 64%(32/ 50),but DLL4 was negatively expressed in all specimens of normal bladder tissue,only one specimen was VEGF positive(P<0.05).The expression of DLL4 had a negative correlation with pathological stage in patients with BTCC,the expression of VEGF had a positive correlation with pathological stage(P<0.05).The expression of DLL4 had a negative correlation with clinical grade in patients with BTCC,the expression of VEGF had a positive correlation with clinical grade(P<0.05).The positive expression of DLL4 and VEGF between the primary tumors and the recurrences were significantly different(P<0.05).Significant correlations were found among the expression of DLL4 and VEGF in patients with BTCC(r= -0.604,P = 0.035).Conclusions:In patients with bladder transitional cell carcinoma(BTCC),DLL4 and VEGF expressions were associated with tumor stage,grade and prognosis.Combining the both expression levels of DLL4 and VEGF can evaluate the prognosis of BTCC which contribute to optimize the treatment plan.Targeting DLL4 may be a novel treatment of anti - angiogenesis of tumors.
What problem does this paper attempt to address?